Modulation of glutathione S-transferase alpha by hepatitis B virus and the chemopreventive drug oltipraz

28Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Persistent infection by hepatitis B virus (HBV) and exposure to chemical carcinogens correlates with the prevalence of hepatocellular carcinoma in endemic areas. The precise nature of the interaction between these factors is not known. Glutathione S-transferases (GST) are responsible for the cellular metabolism and detoxification of a variety of cytotoxic and carcinogenic compounds by catalysis of their conjugation with glutathione. Diminished GST activity could enhance cellular sensitivity to chemical carcinogens. We have investigated GST isozyme expression in hepatocellular HepG2 cells and in an HBV-transfected subline. Total GST activity and selenium-independent glutathione peroxidase activity are significantly decreased in HBV transfected cells. On immunoblotting, HBV transfected cells demonstrate a significant decrease in the level of GST Alpha class. Cytotoxicity assays reveal that the HBV transfected cells are more sensitive to a wide range of compounds known to be detoxified by GST Alpha conjugation. Although no significant difference in protein half-life between the two cell lines was found, semi-quantitative reverse transcription-polymerase chain reaction shows a reduced amount of GST Alpha mRNA in the transfected cells. Because the HBV x protein (HBx) seems to play a role in HBV transfection, we also demonstrated that expression of the HBx gene into HepG2 cells decreased the amount of GST Alpha protein. Transient transfection experiments using both rat and human GST Alpha (rGSTA5 and hGSTA1) promoters in HepG2 cells show a decreased CAT activity upon HBx expression, supporting a transcriptional regulation of both genes by HBx. This effect is independent of HBx interaction with Sp1. Treatment with oltipraz, an inducer of GST Alpha, partially overcomes the effect of HBx on both promoters. Promoter deletion studies indicare that oltipraz works through responsive elements distinct from AP1 or NF-κB transcription factors. Thus, HBV infection alters phase II metabolizing enzymes via different mechanisms than those modulated by treatment with oltipraz.

References Powered by Scopus

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen

1652Citations
N/AReaders
Get full text

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

1096Citations
N/AReaders
Get full text

Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease

1095Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The toxicology of aflatoxins as a basis for public health decisions

391Citations
N/AReaders
Get full text

Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression

203Citations
N/AReaders
Get full text

A model of interaction: Aflatoxins and hepatitis viruses in liver cancer aetiology and prevention

151Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Jaitovitch-Groisman, I., Fotouhi-Ardakani, N., Schecter, R. L., Woo, A., Alaoui-Jamali, M. A., & Batist, G. (2000). Modulation of glutathione S-transferase alpha by hepatitis B virus and the chemopreventive drug oltipraz. Journal of Biological Chemistry, 275(43), 33395–33403. https://doi.org/10.1074/jbc.M003754200

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

70%

Researcher 3

30%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 5

45%

Pharmacology, Toxicology and Pharmaceut... 2

18%

Medicine and Dentistry 2

18%

Veterinary Science and Veterinary Medic... 2

18%

Save time finding and organizing research with Mendeley

Sign up for free